Showing 25 of 887 items meeting your criteria.
| | Type | Category | Supplier | |
|---|
| |
 | TargetMol offers hundreds of products for disease modelling, covering a wide range of disease models including cancer, neurological disorders, immune and inflammatory conditions, endocrine and metabolic diseases, as well as cardiovascular diseases. |
Documents | Catalogue | TargetMol | |
 | TargetMol, as a professional one-stop platform for drug discovery, offers a variety of products related to Endocrinology and Metabolism. |
Documents | Metabolism | TargetMol | |
 | HTS, which emerged in the 1990s, is a new model for drug discovery that integrates advanced technology in chemistry, biology, bioinformatics and automation. |
Documents | Drug Discovery | TargetMol | |
 | As a one-stop drug screening expert, TargetMol offers stable products with a wide variety, providing a range of inhibitors & agonists, recombinant proteins, compound libraries and drug-like compound libraries related to cardiovascular diseases. |
Documents | Cardiovascular | TargetMol | |
 | TargetMol offers a catalogue of small molecules, custom synthesis, CADD and compound libraries. |
Documents | Small Molecules | TargetMol | |
 | Computer-Aided Drug Design (CADD) is a technology that utilises computer techniques to discover and optimise active lead compounds into candidate drugs. Artificial Intelligence-Driven Drug Discovery (AIDD) utilises AI technology to improve the efficiency and success rate of the drug discovery and design process. |
Documents | Drug Discovery | TargetMol | |
 | TargetMol provides a range of kits for life science research. |
Documents | Kits | TargetMol | |
 | Drug-Like Compounds, as a class of small molecules with drug potential, serve as an important source for small-molecule drug discovery. They are typically derived from existing drugs through structural modifications or improvements to achieve better efficacy or reduce adverse effects. Drug-like compounds help researchers gain insights from existing drugs, enabling the rapid development of novel therapeutics and improving research and development efficiency. |
Documents | Small Molecules | TargetMol | |
 | TargetMol currently offers over 14,500 recombinant protein products, including cytokines, growth factors, receptor proteins, enzymes and viral proteins. |
Documents | Recombinant Proteins | TargetMol | |
 | TargetMol currently offers more than 3,000 inhibitory antibody products, including biosimilar antibodies, bispecific antibodies, antibody-drug conjugates (ADCs) and anti-mouse/anti-rat in vivo antibodies. |
Documents | Antibodies | TargetMol | |
 | Protein-protein interactions (PPIs) are the cornerstone of life processes and a "goldmine" of targets for next-generation drug development. Yet, PPI-targeted drug discovery often hits a wall: groundbreaking mechanisms are identified, but validated lead compounds remain elusive—leaving researchers with "no ingredients to cook with." |
Documents | Service | TargetMol | |
 | TargetMol offers over 14,500 detection antibodies covering a wide range of research areas and classic signalling pathways. |
Documents | Antibodies | TargetMol | |
 | TargetMol provides inhibitors, agonists and compound libraries targeting ion channels. |
Documents | Small Molecules | TargetMol | |
 | Inhibitors & Agonists, Natural Products, Recombinant Proteins, PROTAC, Peptides, Dye Reagents, Inhibitory Antibody & ADC, Disease Modelling Products, Kits and Antibodies. |
Documents | Supplier Introduction | TargetMol | |
 | TargetMol currently offers over 1,600 ADC-related products, covering ADCs as well as their corresponding antibodies, payloads, linkers, and related recombinant proteins. |
Documents | Drug Discovery | TargetMol | |
 | hPCMA is an innovative human placenta-derived material with tunable mechanical properties, offering collagen-rich microenvironment for 3D cell culture that supports cell adhesion, growth and proliferation. |
Documents | Cell Culture | Metatissue | |
 | Redefining T-cell activation. |
Documents | Cell Culture | Bio-ReCell | |
 | T-cell activation reagent, based on non-magnetic beads. |
Documents | Cell Culture | Bio-ReCell | |
 | The Atract™ Kit produces a fast and strong activation response from naïve T cells, promoting high proliferation and expansion of activated cells. |
Documents | Cell Culture | Bio-ReCell | |
 | SAFETY DATA SHEET for Atract™ T-Cell Activation Kit V2, CD2/CD3/CD28 |
Documents | Datasheets | Bio-ReCell | |
 | SAFETY DATA SHEET for Atract™ T-Cell Activation Kit V1, CD3/CD28 |
Documents | Datasheets | Bio-ReCell | |
 | Advancing science with reliable, high-performance qPCR |
Documents | PCR Kits | Applied Biological Materials (abm) | |
 | abms mycoplasma detection kits provide reliable contamination monitoring across routine and critical workflows. Designed to support experimental accuracy and reproducibility, they help ensure confidence in cell culture-based research. |
Documents | PCR Kits | Applied Biological Materials (abm) | |
 | Applied Biological Materials isnt just your personal Cell Designer — they offer a broad range of cell culture materials to support your entire workflow. |
Documents | Cell Culture | Applied Biological Materials (abm) | |
 | No matter your research goals, abm are confident their premium enzymes will deliver the reliability and performance your projects demand. |
Documents | Molecular Biology | Applied Biological Materials (abm) | |